Azimuth Capital Management’s Zimmer Biomet ZBH Stock Holding History

Azimuth Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,324	Closed	-$207K	–	328
2021 Q2	$207K	Hold	1,324	–	–	0.01%	318
2021 Q1	$206K	Buy	+1,324	New	+$205K	0.01%	306
2019 Q2	–	Sell	-1,860	Closed	-$231K	–	286
2019 Q1	$231K	Buy	+1,860	New	+$211K	0.02%	270
2018 Q4	–	Sell	-1,860	Closed	-$237K	–	293
2018 Q3	$237K	Hold	1,860	–	–	0.02%	274
2018 Q2	$201K	Buy	+1,860	New	+$202K	0.01%	281
2018 Q1	–	Sell	-2,169	Closed	-$254K	–	292
2017 Q4	$254K	Hold	2,169	–	–	0.02%	275
2017 Q3	$247K	Buy	+2,169	New	+$250K	0.02%	273
2016 Q1	–	Sell	-2,530	Closed	-$252K	–	274
2015 Q4	$252K	Buy	+2,530	New	+$248K	0.02%	254
2015 Q3	–	Sell	-1,983	Closed	-$210K	–	290
2015 Q2	$210K	Buy	+1,983	New	+$219K	0.02%	282

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Azimuth Capital Management's ZBH Position: Q3 2021 in Review

Azimuth Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 1,324 shares — an estimated $207K sold.

Azimuth Capital Management first reported a position in ZBH in Q2 2015 and held it in 9 quarters. The position peaked at $254K in Q4 2017. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

Azimuth Capital Management reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
Azimuth Capital Management sold 1,324 Zimmer Biomet shares in Q3 2021, an estimated $207K.
Azimuth Capital Management first reported a position in Zimmer Biomet in Q2 2015 and held it in 9 quarters.
Azimuth Capital Management's Zimmer Biomet position peaked at $254K in Q4 2017.
982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Azimuth Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.